col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Journal of Infection and Chemotherapy
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―11 Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan Hiroki Kitagawa, Yuki Kaiki, Aya Sugiyama, Shintaro Nagashima, Akemi Kurisu, Toshihito Nomura, et al. (+5)
2 [GO] 2022―Jan―06 Clinical features and outcomes of coronavirus disease 2019 in early infants in Japan: A case series and literature review Hiroyuki Iijima, Takanori Funaki, Mitsuru Kubota
3 [GO] 2022―Jan―05 Impact of regional heterogeneity on the severity of COVID-19 Shinya Tsuzuki, Yusuke Asai, Nobuaki Matsunaga, Haruhiko Ishioka, Takayuki Akiyama, Norio Ohmagari
4 [GO] 2022―Jan―03 Surgically treated reactive arthritis of the ankle after COVID-19 infection: A case report Kohei Shimoyama, Atsushi Teramoto, Yasutaka Murahashi, Katsunori Takahashi, Kota Watanabe, Kousuke Iba, Toshihiko Yamashita
5 [GO] 2021―Dec―31 Ivermectin administration is associated with lower gastrointestinal complications and greater ventilator-free days in ventilated patients with COVID-19: A propensity score analysis Kentaro Shimizu, Haruhiko Hirata, Daijiro Kabata, Natsuko Tokuhira, Moe Koide, Akiko Ueda, et al. (+5)
6 [GO] 2021―Dec―31 Clinical eEvaluation of the rRapid nNucleic aAcid aAmplification pPoint-of-cCare tTest (Smart Gene SARS-CoV-2) in the aAnalysis of nNasopharyngeal and aAnterior nNasal samples. Yoshihiko Kiyasu, Masato Owaku, Yusaku Akashi, Yuto Takeuchi, Kenji Narahara, Sunao Mori, et al. (+6)
7 [GO] 2021―Dec―30 Safety and Immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Wataru Hojo, Hironori Sakai, Ryo Takai, et al. (+12)
8 [GO] 2021―Dec―30 Antibody responses induced by the BNT162b2 mRNA COVID-19 vaccine in healthcare workers in a single community hospital in Japan Shinya Otsuka, Kei Hiraoka, Masato Suzuoki, Hideki Ujiie, Tatsuya Kato, Isao Yokota, et al. (+5)
9 [GO] 2021―Dec―15 A warning related to predicting the severity of COVID-19 pneumonia using the A-DROP scoring system Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Shosaku Nomura
10 [GO] 2021―Dec―07 Interpretations of SARS-CoV-2 IgM and IgG antibody titers in the seroepidemiological study of asymptomatic healthy volunteers Akihisa Mitani, Takeshi Horie, Rin Yokoyama, Yuki Nakano, Kensuke Hamada, Yukiko Inoue, et al. (+15)
11 [GO] 2021―Nov―30 Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system Yoshikazu Mutoh, Takumi Umemura, Aiko Ota, Keisuke Okuda, Ryoma Moriya, Mayumi Tago, et al. (+16)
12 [GO] 2021―Nov―29 Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay Hideaki Kato, Kei Miyakawa, Norihisa Ohtake, Hirofumi Go, Yutaro Yamaoka, Satoshi Yajima, et al. (+4)
13 [GO] 2021―Nov―25 Recovery from severe persistent COVID-19 without evidence of an anti-SARS-CoV-2 antibody response in a man with mantle cell lymphoma treated with rituximab Hiroshi Horiuchi, Hiroaki Sasaki, Kazuhito Miyazaki, Nobuyuki Miyata, Yukihiro Yoshimura, Natsuo Tachikawa
14 [GO] 2021―Nov―17 Omental infarction in mild Covid-19 infection Abdurrahman Kaya, Sibel Yıldız Kaya, Hakan Baydar, Işıl Bavunoğlu
15 [GO] 2021―Nov―17 The effect of higher-intensity-dosing anticoagulation in the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
16 [GO] 2021―Nov―13 Stability of SARS-CoV-2 and influenza virus varies across different paper types Ryohei Hirose, Hajime Miyazaki, Risa Bandou, Naoto Watanabe, Takuma Yoshida, Tomo Daidoji, et al. (+2)
17 [GO] 2021―Nov―12 Potential for false-positive results with quantitative antigen tests for SARS-CoV-2: A case of a child with acute respiratory infection Ryota Hase, Takashi Kurita, Haruki Mito, Yudai Yano, Tomohisa Watari, Yoshihito Otsuka, et al. (+2)
18 [GO] 2021―Nov―10 Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients Emiko Igarashi, Hideki Tani, Kosuke Tamura, Masae Itamochi, Takahisa Shimada, Yumiko Saga, et al. (+16)
19 [GO] 2021―Nov―10 Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2 Yusaku Akashi, Yoshihiko Kiyasu, Yuto Takeuchi, Daisuke Kato, Miwa Kuwahara, Shino Muramatsu, et al. (+5)
20 [GO] 2021―Nov―10 A study of quality assessment in SARS-CoV-2 pathogen nucleic acid amplification tests performance; from the results of external quality assessment survey of clinical laboratories in the Tokyo Metropolitan Government external quality assessment program in 2020 Yoshikazu Ishii, Kotaro Aoki, Mayuko Oda, Megumi Ichikawa, Rie Moriuchi, Hiroyuki Konishi, et al. (+3)
21 [GO] 2021―Nov―09 Indications for SARS-CoV-2 nucleic acid amplification test for areas with low endemicity Hisao Higo, Yoshinori Taguchi, Noriyuki Suzaki, Takuya Nagata, Masaomi Marukawa
22 [GO] 2021―Oct―30 Corrigendum to ’ Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients’[27 (2021) 1669-1673] Hidetoshi Nomoto, K. Yamamoto
23 [GO] 2021―Oct―28 Clinical Characteristics and Prognosis of Immunosuppressed Inpatients with COVID-19 in Japan Hidetoshi Nomoto, Setsuko Suzuki, Yusuke Asai, Kayoko Hayakawa, Hiroyuki Gatanaga, Mari Terada, et al. (+4)
24 [GO] 2021―Oct―27 Diagnostic performance of a novel digital immunoassay (RapidTesta SARS-CoV-2): A prospective observational study with nasopharyngeal samples Hiromichi Suzuki, Yusaku Akashi, Atsuo Ueda, Yoshihiko Kiyasu, Yuto Takeuchi, Yuta Maehara, et al. (+5)
25 [GO] 2021―Oct―25 Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine Susumu Yamazaki, Erika Naito, Ryu Sekiya, Sanehiro Yogi, Kenichiro Komiyama, Yoshitaka Miyakawa, Makoto Nagata
26 [GO] 2021―Oct―22 A fatal case of extensive gastrointestinal necrosis due to portal and mesenteric vein thrombosis in the post-acute phase of COVID-19 Tomohiro Hosoda, Hideki Orikasa
27 [GO] 2021―Oct―22 Fatty Liver on Computed Tomography Scan on Admission is a Risk Factor for Severe Coronavirus Disease Ayako Okuhama, Masatoshi Hotta, Masahiro Ishikane, Akira Kawashima, Yusuke Miyazato, Mari Terada, et al. (+27)
28 [GO] 2021―Oct―22 Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan Tetsuya Suzuki, Yusuke Asai, Satoshi Ide, Saori Fukuda, Akihito Tanaka, Yumiko Shimanishi, et al. (+17)
29 [GO] 2021―Oct―20 Elevated blood favipiravir levels are inversely associated with ferritin levels and induce the elevation of uric acid levels in COVID-19 treatment: A retrospective single-center study Go Morikawa, Ken Kubota, Daichi Kondo, Yasuhisa Takanashi, Satoshi Minami, Tsunemichi Kinjo, et al. (+4)
30 [GO] 2021―Oct―02 Evaluation of minocycline combined with favipiravir therapy in coronavirus disease 2019 patients: a case-series study Kazuhiro Itoh, Ippei Sakamaki, Tomoya Hirota, Hiromichi Iwasaki
31 [GO] 2021―Oct―02 Multisystem inflammatory syndrome in adults after acute coronavirus disease 2019 in a Japanese woman: A case report Kyohei Miyamoto, Yusuke Koizumi, Shinobu Tamura, Tsuyoshi Nakashima, Kaori Kobai, Rikako Tanaka, et al. (+5)
32 [GO] 2021―Sep―21 Comparative study of SmartAmp assay and reverse transcription-polymerase chain reaction by saliva specimen for the diagnosing COVID-19 Nobuhiro Asai, Akiko Nakamura, Daisuke Sakanashi, Isao Koita, Wataru Ohashi, Yuzuka Kawamoto, et al. (+11)
33 [GO] 2021―Sep―20 COVID-19 vaccine induced interstitial lung disease Ayumi Yoshifuji, Kota Ishioka, Yuya Masuzawa, Shuntaro Suda, Saori Murata, Yoshifumi Uwamino, et al. (+6)
34 [GO] 2021―Sep―16 Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers in Japan Mizue Saita, Yan Yan, Kanami Ito, Hiroshi Sasano, Kuniaki Seyama, Toshio Naito
35 [GO] 2021―Sep―10 Duration of infectious virus shedding in patients with severe coronavirus disease 2019 who required mechanical ventilation Toshihito Nomura, Hiroki Kitagawa, Keitaro Omori, Norifumi Shigemoto, Masaki Kakimoto, Tanuza Nazmul, et al. (+3)
36 [GO] 2021―Aug―25 Risk factors in pediatric hospitalization for influenza A and B during the seven seasons immediately before the COVID-19 era in Japan Masayoshi Shinjoh, Munehiro Furuichi, Atsushi Narabayashi, Akinobu Kamei, Naoko Yoshida, Takao Takahashi
37 [GO] 2021―Aug―25 Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): a single-centre randomized, placebo-controlled trial Anant Mohan, Pawan Tiwari, Tejas Menon Suri, Saurabh Mittal, Ankit Patel, Avinash Jain, et al. (+21)
38 [GO] 2021―Aug―16 Does the E gene provide additional information in SARS-CoV-2 PCR? András Zóka, Gabriella Bekő
39 [GO] 2021―Aug―14 Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: the potential contribution to alleviating isolation of COVID-19 patients Hidetoshi Nomoto, Kei Yamamoto, Gen Yamada, Michiyo Suzuki, Noriko Kinoshita, Jin Takasaki, et al. (+4)
40 [GO] 2021―Aug―13 The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019 Goto Norihiko, Yosuke Wada, Yuichi Ikuyama, Jumpei Akahane, Makoto Kosaka, Atsuhito Ushiki, et al. (+8)
41 [GO] 2021―Aug―12 Coronavirus disease (COVID-19) associated delayed-onset fulminant myocarditis in patient with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection Hiroyasu Ishikura, Junichi Maruyama, Kota Hoshino, Yuta Matsuoka, Masaya Yano, Tadaaki Arimura, et al. (+4)
42 [GO] 2021―Aug―12 Antibody response after COVID-19 vaccine BNT162b2 on health care workers in Japan Yukihiro Yoshimura, Hiroaki Sasaki, Nobuyuki Miyata, Kazuhito Miyazaki, Natsuo Tachikawa
43 [GO] 2021―Jul―24 The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan Tomiteru Togano, Yukari Uemura, Yusuke Asai, Kayoko Hayakawa, Nobuaki Matsunaga, Mari Terada, et al. (+9)
44 [GO] 2021―Jul―16 Efficacy and Safety of Hydroxychloroquine/chloroquine against SARS-CoV-2 Infection: A Systematic Review and Meta-analysis - Authors Reply Jogender Kumar, Siddharth Jain, Arushi Yadav, Jitendra Meena
45 [GO] 2021―Jul―16 Discrepancy of SARS-CoV-2 PCR results due to the sample collection sites and possible improper sampling Satoshi Irifune, Nobuyuki Ashizawa, Takahiro Takazono, Pierre Mutantu, Takeshi Nabeshima, Mya Myat Ngwe Tun, et al. (+13)
46 [GO] 2021―Jul―13 The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2 Yoko Kurihara, Yoshihiko Kiyasu, Yusaku Akashi, Yuto Takeuchi, Kenji Narahara, Sunao Mori, et al. (+6)
47 [GO] 2021―Jul―08 Clinical and radiological findings of silent hypoxia among COVID-19 patients Ayako Okuhama, Masahiro Ishikane, Masatoshi Hotta, Lubna Sato, Yutaro Akiyama, Shinichiro Morioka, et al. (+6)
48 [GO] 2021―Jul―05 The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic Taito Kitano
49 [GO] 2021―Jun―25 Evaluation of false positives in the SARS-CoV-2 quantitative antigen test Ryo Kobayashi, Ryosei Murai, Mikako Moriai, Shinya Nirasawa, Hitoshi Yonezawa, Takashi Kondoh, et al. (+9)
50 [GO] 2021―Jun―12 Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort Masahiro Suzuki, Takumi Imai, Aki Sakurai, Satoshi Komoto, Tomihiko Ide, Chang Kweng Lim, et al. (+3)
51 [GO] 2021―Jun―12 Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS) Akihisa Mitani, Kensuke Hamada, Naoyuki Yoshikawa, Yoshifumi Morita, Takeshi Horie, Yukiko Inoue, et al. (+14)
52 [GO] 2021―Jun―12 Development of a genotyping platform for SARS-CoV-2 variants using high-resolution melting analysis Akira Aoki, Yoko Mori, Yoshinori Okamoto, Hideto Jinno
53 [GO] 2021―Jun―04 Response to: Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: a systematic review and meta-analysis Lucio Boglione, Roberto Rostagno, Federica Poletti, Roberta Moglia, Bianca Bianchi, Maria Esposito, Silvio Borrè
54 [GO] 2021―May―12 Tocilizumab in COVID-19: the Cerrahpaşa-PREDICT score Ahmet Emre Eşkazan, İlker İnanç Balkan, Kaan Can Demirbaş, Muhlis Cem Ar, Rıdvan Karaali, Yonca Sekibağ, et al. (+16)
55 [GO] 2021―May―12 Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result? Kei Yamamoto, Mami Nagashima, Isao Yoshida, Kenji Sadamasu, Masami Kurokawa, Maki Nagashima, et al. (+5)
56 [GO] 2021―May―11 Scoring system for identifying Japanese patients with COVID-19 at risk of requiring oxygen supply: A retrospective single-center study Heita Kitajima, Tomonori Hirashima, Hidekazu Suzuki, Tsuyoshi Arai, Yoshitaka Tamura, Shoji Hashimoto, et al. (+7)
57 [GO] 2021―May―11 Evaluation of SARS-CoV-2 RNA quantification by RT-LAMP compared to RT-qPCR Kenta Minami, Ryota Masutani, Youichi Suzuki, Meri Kubota, Naofumi Osaka, Toyofumi Nakanishi, et al. (+2)
58 [GO] 2021―May―09 A patient with human coronavirus NL63 falsely diagnosed with COVID-19; Lesson learned for the importance of definitive diagnosis Yuki Otsuka, Hideharu Hagiya, Yasuhiro Nakano, Daisuke Omura, Kou Hasegawa, Haruto Yamada, et al. (+3)
59 [GO] 2021―Apr―24 Asymptomatic COVID-19 Re-infection in a Japanese Male by Elevated Half-Maximal Inhibitory Concentration (IC50) of Neutralizing Antibodies Makoto Inada, Masahiro Ishikane, Mari Terada, Akihiro Matsunaga, Kenji Maeda, Kiyoto Tsuchiya, et al. (+8)
60 [GO] 2021―Apr―19 Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients Satoshi Fujii, Yuta Ibe, Tomoyuki Ishigo, Toshihiro Inamura, Yusuke Kunimoto, Yoshihiro Fujiya, et al. (+4)
61 [GO] 2021―Apr―19 Accuracy of Rapid Antigen Detection Test for Nasopharyngeal Swab Specimens and Saliva Samples in Comparison with RT-PCR and Viral Culture for SARS-CoV-2 Detection Yoshifumi Uwamino, Mika Nagata, Wataru Aoki, Terumichi Nakagawa, Rika Inose, Hiromitsu Yokota, et al. (+6)
62 [GO] 2021―Apr―16 False-positive for SARS-CoV-2 antigen test in a man with acute HIV infection Kazutaka Yamaniha, Takeshi Kinjo, Morikazu Akamine, Michika Setoguchi, Masao Tateyama, Jiro Fujita
63 [GO] 2021―Apr―15 Letter of concern re: “Immunochromatographic test for the detection of SARS-CoV-2 in saliva. J Infect Chemother. 2021 Feb;27(2):384-386. doi: 10.1016/j.jiac.2020.11.016.” Giuseppe Sberna, Eleonora Lalle, Maria Rosaria Capobianchi, Licia Bordi, Alessandra Amendola
64 [GO] 2021―Apr―13 External Validation and Update of Prediction Models for Unfavorable Outcomes in Hospitalized Patients with COVID-19 in Japan Gen Yamada, Kayoko Hayakawa, Yusuke Asai, Nobuaki Matsunaga, Hiroshi Ohtsu, Masayuki Hojo, et al. (+14)
65 [GO] 2021―Apr―08 Invasive pneumococcal disease affected the fatal outcome in a COVID-19 patient Koji Kuronuma, Naofumi Bunya, Bin Chang, Yoshihiro Fujiya, Kazunori Oishi, Eichi Narimatsu, et al. (+2)
66 [GO] 2021―Apr―08 Investigation of nasopharyngeal viral load at discharge in patients with COVID-19 Yasutaka Fukui, Hitoshi Kawasuji, Yusuke Taekgoshi, Makito Kaneda, Yushi Murai, Kou Kimoto, et al. (+6)
67 [GO] 2021―Apr―02 Efficacy and validity of automated quantitative chemiluminescent enzyme immunoassay for SARS-CoV-2 antigen test from Saliva specimen in the diagnosis of COVID-19 Nobuhiro Asai, Daisuke Sakanashi, Wataru Ohashi, Akiko Nakamura, Yuzuka Kawamoto, Narimi Miyazaki, et al. (+12)
68 [GO] 2021―Apr―02 A fatal case of COVID-19-associated invasive pulmonary aspergillosis Yuto Iwanaga, Toshinori Kawanami, Kei Yamasaki, Hideki Sakakibara, Issei Ikusima, Hiroaki Ikegami, et al. (+4)
69 [GO] 2021―Mar―29 Successful deceased donor kidney transplantation to a recipient with a history of COVID-19 treatment K. Yoshinaga, M. Araki, K. Wada, S. Sekito, T. Miyake, S. Watari, et al. (+19)
70 [GO] 2021―Mar―27 Cervical abscess caused by methicillin-susceptible Staphylococcus aureus in an infant infected with SARS-CoV-2: Diagnostic dilemma Sema Yildirim Arslan, Zumrut Sahbudak Bal, Gizem Guner Ozenen, Nimet Melis Bilen, Zafer Kurugol, Ferda Ozkinay
71 [GO] 2021―Mar―23 False positive results in severe acute respiratory coronavirus 2 (SARS-CoV-2) rapid antigen tests for inpatients Kazuhiro Itoh, Toru Kawamitsu, Yoko Osaka, Kazuyo Sato, Yusuke Suzuki, Chiyo Kiriba, et al. (+8)
72 [GO] 2021―Mar―18 Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests Nobuyuki Ashizawa, Takahiro Takazono, Kaname Ohyama, Yoji Nagasaki, Masaki Okamoto, Tatsuro Hirayama, et al. (+16)
73 [GO] 2021―Mar―12 Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged population Akitoshi Ueno, Hitoshi Kawasuji, Yuki Miyajima, Yasutaka Fukui, Ippei Sakamaki, Mayuko Saito, et al. (+4)
74 [GO] 2021―Mar―07 Clinical Characteristics of Japanese Patients with Moderate to Severe COVID-19 Ryota Otoshi, Eri Hagiwara, Takaaki Kitayama, Takafumi Yamaya, Katsuyuki Higa, Kota Murohashi, et al. (+14)
75 [GO] 2021―Mar―07 The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan Yuto Takeuchi, Yusaku Akashi, Daisuke Kato, Miwa Kuwahara, Shino Muramatsu, Atsuo Ueda, et al. (+4)
76 [GO] 2021―Feb―26 Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis Toshiaki ISHII, Masakazu SASAKI, Kageto YAMADA, Daiki KATO, Hiroyoshi OSUKA, Kotaro AOKI, et al. (+3)
77 [GO] 2021―Feb―26 COVID-19-associated pulmonary aspergillosis in a Japanese man: A case report Waki Imoto, Hoshi Himura, Kenji Matsuo, Sae Kawata, Ayako Kiritoshi, Ryo Deguchi, et al. (+10)
78 [GO] 2021―Feb―23 Efficacy and Safety of Hydroxychloroquine/chloroquine against SARS-CoV-2 Infection: A Systematic Review and Meta-analysis Jogender Kumar, Siddharth Jain, Jitendra Meena, Arushi Yadav
79 [GO] 2021―Feb―21 A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe COVID-19 Wei-Jing Gong, Tao Zhou, San-Lan Wu, Jia-Long Ye, Jia-Qiang Xu, Fang Zeng, et al. (+5)
80 [GO] 2021―Feb―21 Prevalence of thromboembolic events and status of prophylactic anticoagulant therapy in hospitalized patients with COVID-19 in Japan Sho Fujiwara, Mikio Nakajima, Richard H. Kaszynski, Kazuaki Fukushima, Masaru Tanaka, Keishiro Yajima, et al. (+9)
81 [GO] 2021―Feb―21 Factors associated with viral clearance periods from patients with COVID-19: A retrospective observational cohort study Nobuyasu Hirai, Yuichi Nishioka, Takahiro Sekine, Yuji Nishihara, Nao Okuda, Tomoko Nishimura, et al. (+12)
82 [GO] 2021―Feb―17 Predictors associated with clinical improvement of SARS-CoV-2 pneumonia Takahiro Mitsumura, Tsukasa Okamoto, Tsuyoshi Shirai, Yuki Iijima, Rie Sakakibara, Takayuki Honda, et al. (+12)
83 [GO] 2021―Feb―06 A comparison on the percentage of polymerase chain reaction positivity for SARS-CoV-2 between Public Health Center referrals and direct walk-in patients: A single center retrospective analysis in Tokyo Mikio Nakajima, Yasuhiro Yamamoto, Richard H. Kaszynski, Yuko Yamauchi, Kazuo Yamamoto, Yasushi Nakajima, et al. (+5)
84 [GO] 2021―Jan―23 Ventilator-associated bacterial pneumonia in Coronavirus 2019 disease, a retrospective monocentric cohort study Marco Moretti, Johan Van Laethem, Andrea Minini, Denis Pierard, Manu L.N.G. Malbrain
85 [GO] 2021―Jan―19 Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19 Satoshi Kutsuna, Yusuke Asai, Akihiro Matsunaga, Noriko Kinoshita, Mari Terada, Yusuke Miyazato, et al. (+10)
86 [GO] 2021―Jan―18 No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity Hidetoshi Nomoto, Satoshi Kutsuna, Kazu Okuma, Madoka Kuramitsu, Kenta Tezuka, Emi Ikebe, et al. (+10)
87 [GO] 2021―Jan―18 Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS-CoV-2 antigen Ryo Kobayashi, Ryosei Murai, Kouichi Asanuma, Yoshihiro Fujiya, Satoshi Takahashi
88 [GO] 2020―Dec―28 Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19 Shingo Yamazaki, Takaaki Suzuki, Misa Sayama, Taka-aki Nakada, Hidetoshi Igari, Itsuko Ishii
89 [GO] 2020―Dec―23 Two cases of novel coronavirus infection (COVID-19) with transient viral elevation using semi-quantitative real-time reverse transcription PCR and symptom relapse after completion of 10 days of favipiravir treatment Hajime Tsuboi, Yu Kasamatsu, Shin Matsubara, Akifumi Sasao, Katsutomo Kunimitsu, Nana Munakata, et al. (+4)
90 [GO] 2020―Dec―23 Evaluation of Clinical Utility of Novel Coronavirus Antigen Detection Reagent, Espline® SARS-CoV-2 Kotaro Aoki, Tatsuya Nagasawa, Yoshikazu Ishii, Shintaro Yagi, Katsuhito Kashiwagi, Taito Miyazaki, Kazuhiro Tateda
91 [GO] 2020―Dec―23 Immunochromatographic test for the detection of SARS-CoV-2 in saliva Katsuhito Kashiwagi, Yoshikazu Ishii, Kotaro Aoki, Shintaro Yagi, Maeda Tadashi, Taito Miyazaki, et al. (+3)
92 [GO] 2020―Dec―17 Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: a modelling study Yusuke Asai, Shinya Tsuzuki, Satoshi Kutsuna, Kayoko Hayakawa, Norio Ohmagari
93 [GO] 2020―Dec―17 Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring systems Tatsuya Kodama, Hirofumi Obinata, Hitoshi Mori, Wakana Murakami, Yohsuke Suyama, Hisashi Sasaki, et al. (+4)
94 [GO] 2020―Dec―05 Experience of 101 patients with Coronavirus Infectious Disease 2019 (COVID-19) at a tertiary care center in Japan Kenta Yao, Shinya Hasegawa, Yasuaki Tagashira, Akane Takamatsu, Yuki Uenoyama, Keiki Shimizu, et al. (+40)
95 [GO] 2020―Dec―04 Prolonged Viral Shedding of SARS-CoV-2 in an immunocompromised Patient Yukiko Nakajima, Asuca Ogai, Karin Furukawa, Ryosuke Arai, Ryusuke Anan, Yasushi Nakano, et al. (+4)
96 [GO] 2020―Dec―03 Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs Kotaro Aoki, Tatsuya Nagasawa, Yoshikazu Ishii, Shintaro Yagi, Sadatsugu Okuma, Katsuhito Kashiwagi, et al. (+4)
97 [GO] 2020―Oct―31 SARS-CoV-2 detection by fluorescence loop-mediated isothermal amplification with and without RNA extraction Keisuke Taki, Isao Yokota, Tatsuya Fukumoto, Sumio Iwasaki, Shinichi Fujisawa, Masayoshi Takahashi, et al. (+9)
98 [GO] 2020―Oct―30 Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection Yosuke Hirotsu, Makoto Maejima, Masahiro Shibusawa, Kenji Amemiya, Yuki Nagakubo, Kazuhiro Hosaka, et al. (+7)
99 [GO] 2020―Oct―23 Clinical characteristics of adult patients hospitalized with laboratory-confirmed COVID-19 pneumonia Elif Sargin Altunok, Mustafa Alkan, Sadettin Kamat, Berna Demirok, Celal Satici, Mustafa Asim Demirkol, et al. (+5)
100 [GO] 2020―Oct―16 Critically ill patients with COVID-19 in Tokyo, Japan: a single-center case series Satoshi Miike, Naoya Sakamoto, Takuya Washino, Atsushi Kosaka, Yusuke Kuwahara, Takuto Ishida, et al. (+5)
101 [GO] 2020―Oct―13 MuLBSTA score is a useful tool for predicting COVID-19 disease behavior Yuki Iijima, Tsukasa Okamoto, Tsuyoshi Shirai, Takahiro Mitsumura, Rie Sakakibara, Takayuki Honda, et al. (+8)
102 [GO] 2020―Oct―10 A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful Takatomo Hirouchi, Shinichiro Ota, Dai Mashima, Ryuichi Boku, Yuto Yoshida, Koki Iwata, et al. (+7)
103 [GO] 2020―Oct―10 Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study Tomonori Hirashima, Tsuyoshi Arai, Heita Kitajima, Yoshitaka Tamura, Tomoki Yamada, Shoji Hashimoto, et al. (+11)
104 [GO] 2020―Oct―06 Myocardial injury in a patient with severe coronavirus disease: A case report Yuki Nakamura, Masaru Shimizu, Taeka Yamaki, Kohsuke Kushimoto, Ayahiro Yamashita, Kazuma Hayase, et al. (+3)
105 [GO] 2020―Sep―30 Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19 Daisuke Sakanashi, Nobuhiro Asai, Akiko Nakamura, Narimi Miyazaki, Yuzuka Kawamoto, Tomoko Ohno, et al. (+14)
106 [GO] 2020―Sep―30 Severe olfactory and gustatory dysfunctions in a Japanese pediatric patient with coronavirus disease (COVID-19) Yuki Kasuga, Koji Nishimura, Hidetoshi Go, Kimitaka Nakazaki, Shoichi Shimizu, Koji Kanezawa, et al. (+3)
107 [GO] 2020―Sep―29 CT Screening for COVID-19 in Asymptomatic Patients before Hospital Admission Sho Uchida, Shunsuke Uno, Yoshifumi Uwamino, Masahiro Hashimoto, Shusuke Matsumoto, Hideaki Obara, et al. (+3)
108 [GO] 2020―Sep―10 COVID-19 Outbreak in Italy: Clinical-Radiological Presentation and Outcome in Three Oncologic Patients Davide Colombi, Flavio Cesare Bodini, Nicola Morelli, Mario Silva, Gianluca Milanese, Luigi Cavanna, Emanuele Michieletti
109 [GO] 2020―Sep―09 Could threshold cycle value correctly reflect the severity of novel coronavirus disease 2019 (COVID-19)? Nobuhiro Asai, Daisuke Sakanashi, Wataru Ohashi, Akiko Nakamura, Atsuko Yamada, Yuzuka Kawamoto, et al. (+11)
110 [GO] 2020―Sep―09 Effectiveness of Personal Protective Equipment in Preventing Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Healthcare Workers Tetsuya Suzuki, Kayoko Hayakawa, Akira Ainai, Naoko Iwata-Yoshikawa, Kaori Sano, Noriyo Nagata, et al. (+17)
111 [GO] 2020―Sep―09 Corticosteroids as adjunctive therapy in the treatment of coronavirus disease 2019: a report of two cases and literature review Makoto Kosaka, Yoshitaka Yamazaki, Takashi Maruno, Koji Sakaguchi, Shoji Sawaki
112 [GO] 2020―Sep―06 Survey of the current status of subclinical coronavirus disease 2019 (COVID-19) Ikuro Matsuba, Nobuo Hatori, Norihiko Koido, Yoshiyuki Watanabe, Futoshi Ebara, Yoko Matsuzawa, et al. (+6)
113 [GO] 2020―Sep―06 Comparison of COVID-19 Disease between Young and Elderly patients: Hidden Viral Shedding of COVID-19 Hitoshi Mori, Hirofumi Obinata, Wakana Murakami, Kodama Tatsuya, Hisashi Sasaki, Yu Miyake, et al. (+5)
114 [GO] 2020―Aug―20 Monitoring of viral load by RT-PCR caused decision making to continue ECMO therapy for a patient with COVID-19 I. Sakamaki, Y. Morinaga, H. Tani, Y. Takegoshi, Y. Fukui, H. Kawasuji, et al. (+9)
115 [GO] 2020―Aug―19 Estimated effectiveness of school closure and voluntary event cancellation as COVID-19 countermeasures in Japan Junko Kurita, Tamie Sugawara, Yasushi Ohkusa
116 [GO] 2020―Aug―06 Clinical improvement in a patient with severe coronavirus disease 2019 after administration of hydroxychloroquine and continuous hemodiafiltlation with nafamostat mesylate Sho Iwasaka, Yuji Shono, Kentaro Tokuda, Kosuke Nakashima, Yuzo Yamamoto, Jun Maki, et al. (+4)
117 [GO] 2020―Aug―05 No intrauterine vertical transmission in pregnancy with COVID-19: a case report Yantian Lv, Binbin Gu, Ying Chen, Siming Hu, Ting Ruan, Guopeng Xu, et al. (+3)
118 [GO] 2020―Jul―17 Serial serum SARS-CoV-2 RNA results in two COVID-19 cases with severe respiratory failure Tatsuya Kodama, Yuji Kouzaki, Shuichi Kawano, Hirofumi Obinata, Hiroaki Taniguchi, Hisashi Sasaki, et al. (+3)
119 [GO] 2020―Jul―01 Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide Hiroaki Baba, Hajime Kanamori, Kengo Oshima, Issei Seike, Ikumi Niitsuma-Sugaya, Kentaro Takei, et al. (+3)
120 [GO] 2020―Jun―24 Incubation period of the coronavirus disease 2019 (COVID-19) in Busan, South Korea Hansol Lee, Kyungtae Kim, Kwonkyu Choi, Sangbum Hong, Hyunjin Son, Sukhyun Ryu
121 [GO] 2020―Jun―13 A case report of SARS-CoV-2 confirmed in saliva specimens up to 37 days after onset: Proposal of saliva specimens for COVID-19 diagnosis and virus monitoring Yasuhisa Tajima, Yasuo Suda, Kunio Yano
122 [GO] 2020―Jun―12 Clinical characteristics of the coronavirus disease 2019 (COVID-19) outbreak on a cruise ship Yukihiro Yoshimura, Hiroaki Sasaki, Hiroshi Horiuchi, Nobuyuki Miyata, Natsuo Tachikawa
123 [GO] 2020―May―21 Imported and locally transmitted mild SARS-CoV-2 pneumonia cases in Japan Kentaro Tochitani, Nobuki Iwamoto, Hirofumi Motobayashi, Shungo Yamamoto, Tsunehiro Shimizu
124 [GO] 2020―May―13 Clinical course of 2019 novel coronavirus disease (COVID-19) in individuals present during the outbreak on the Diamond Princess cruise ship Hideaki Kato, Hiroyuki Shimizu, Yasushi Shibue, Tomohiro Hosoda, Keisuke Iwabuchi, Kotaro Nagamine, et al. (+33)
125 [GO] 2020―May―08 Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results in the early phase of infection Tetsuya Suzuki, Satoshi Kutsuna, Keiji Nakamura, Satoshi Ide, Yuki Moriyama, Sho Saito, et al. (+5)
126 [GO] 2020―Apr―18 A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo, Japan: A case report Kazuha Nakamura, Mayu Hikone, Hiroshi Shimizu, Yusuke Kuwahara, Maki Tanabe, Mioko Kobayashi, et al. (+5)
127 [GO] 2020―Apr―16 Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases Keisuke Iwabuchi, Koichiro Yoshie, Yuichi Kurakami, Kota Takahashi, Yoshio Kato, Tsuneo Morishima


[de][en]

Last change 2022―Jan―20 20:43:25 UTC

© Daten-Quadrat 2022       Done in 0.006 sec